Skip to main content
Clinical Trials/EUCTR2010-022460-12-DK
EUCTR2010-022460-12-DK
Active, not recruiting
Not Applicable

The effect of melatonin on depression, anxiety, cogntive function and sleep disturbances in breast cancer patients - MELODY

Herlev Hospital0 sitesFebruary 11, 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Herlev Hospital
Status
Active, not recruiting
Last Updated
12 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 11, 2011
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Women aged 30\-70 years who are admitted to have a lumpectomy or mastectomy at Herlev Hospital \- department F.
  • ASA score I\-III
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • 1\.Known and treated sleep apnea syndrome
  • 2\.Diabetes mellitus – treated with insulin
  • 3\.Known depressive illness \- medically treated
  • 4\.Previous medically treated depression or bipolar disorder
  • 5\.Previous or ongoing cancer\-disease
  • 6\.Other medically treated sleep disorders
  • 7\.Shiftwork
  • 8\.Pre\-operative treatment with psychopharmaceuticals (narcotics and sedatives)
  • 9\.Pregnant or breastfeeding women
  • 10\.Pre\-operative mini mental state examination score (MMSE) \< 24

Outcomes

Primary Outcomes

Not specified

Similar Trials